New studies have enabled the investigation of MG and MDMs and their distinct contributions to glioblastoma based on identifying distinguishing markers such as MDM-specific expression of CD49d and expression of Tmem119, CX3CR1 and SiglecH on MG (34, 97, 98). Here, ITGA4 is linked to glioblastoma.